昭衍新药 (603127.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(昭衍新药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年三季报2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
主要指标:
 营业收入(元) 会员可见会员可见会员可见会员可见1,335,156,050.40849,356,544.11324,809,103.67
 营业利润(元) 会员可见会员可见会员可见会员可见-69,661,013.72-177,154,741.30-293,008,274.73
 利润总额(元) 会员可见会员可见会员可见会员可见-69,892,269.79-177,351,107.31-293,130,015.64
 净利润(元) 会员可见会员可见会员可见会员可见-74,244,009.94-172,238,316.14-273,363,603.07
 归属于母公司股东的净利润(元) 会员可见会员可见会员可见会员可见-70,307,075.11-169,742,640.65-272,222,474.99
盈利能力:
 销售毛利率(%) 会员可见会员可见会员可见会员可见27.4830.3732.84
 销售净利率(%) 会员可见会员可见会员可见会员可见-5.56-20.28-84.16
 净资产收益率(%) 会员可见会员可见会员可见----
 总资产报酬率ROA(%) 会员可见会员可见会员可见----
 投入资本回报率ROIC(%) 会员可见会员可见会员可见会员可见-0.86-2.07-3.33
营运能力:
 存货周转率(次) 会员可见会员可见会员可见----
 应收账款周转率(次) 会员可见会员可见会员可见----
 总资产周转率(次) 会员可见会员可见会员可见----
偿债能力:
 资产负债率(%) 会员可见会员可见会员可见会员可见16.1118.0717.87
 股东权益比率(%) 会员可见会员可见会员可见会员可见84.0181.9482.12
 已获利息倍数(倍) 会员可见会员可见会员可见会员可见1.943.9511.46
 流动比率 会员可见会员可见会员可见会员可见4.113.624.64
 速动比率 会员可见会员可见会员可见会员可见2.732.433.40
发展能力:
 营业收入增长率(%) 会员可见会员可见会员可见会员可见-15.87-16.08-12.07
 营业利润增长率(%) 会员可见会员可见会员可见会员可见-117.77-251.62-236.68
 税后利润增长率(%) 会员可见会员可见会员可见会员可见-121.46-287.30-244.98
 净资产增长率(%) 会员可见会员可见会员可见会员可见-2.82-1.27-4.33
 总资产增长率(%) 会员可见会员可见会员可见会员可见-6.91-5.46-7.72

前瞻产业研究院